RedChip Upgrades Osteologix, Inc. (OLGX.OB) Rating from “Speculative Buy” to “Buy”
Osteologix has recently made strong moves and passed major milestones which have been primary motivators for RedChip’s upgraded rating. In the past week, the company announced that it raised approximately $5 million in private placement financing. The CEO commented, “Management believes that the funds received from this financing will enable us to continue operations into the second half of next year, beyond our next critical developmental milestone, which is the release of data results from our Phase II study in the treatment of osteoporosis." The company has also completed its enrollment in the “Strong Study”, completed its phase II clinical…